Article

No Article found
CROSSREF PEER REVIEWED GOOGLE SCHOLAR PLAGIARISM CHECK
ISSN License

Hypertensive Disorders of Pregnancy: Risk Stratification, Prevention and Evidence Based Management

Author: Dr. Sucheta Talele Associate Professor, Obstetrics and Gynecology, GMERS Medical College, Himmatnagar, Gujarat, India

Published On: 2021-03-31

Abstract

Hypertensive disorders of pregnancy remain a major cause of maternal and perinatal morbidity and mortality and include chronic hypertension, gestational hypertension, pre-eclampsia, and pre-eclampsia superimposed on chronic hypertension. This narrative review synthesizes evidence available through 30 June 2021 regarding classification, pathophysiology, prediction, prevention, acute treatment, timing of delivery, and post-partum follow-up. Contemporary diagnostic frameworks emphasize new-onset hypertension after 20 weeks of gestation and recognize that pre-eclampsia can be diagnosed in the absence of proteinuria when specific maternal organ dysfunction or uteroplacental dysfunction is present. Abnormal placentation, endothelial injury, and an imbalance between pro-angiogenic and anti-angiogenic factors provide a biologically plausible model linking placental disease to the maternal syndrome. First-trimester multimarker screening can identify a substantial proportion of pregnancies destined to develop preterm pre-eclampsia, although availability and implementation vary. Low-dose aspirin for appropriately selected high-risk women and calcium supplementation in populations with low dietary calcium intake are the most consistently supported preventive strategies. Severe hypertension requires prompt treatment, magnesium sulfate remains the standard anticonvulsant for eclampsia prevention and treatment, and definitive management of pre-eclampsia ultimately requires delivery, with timing individualized by gestational age, disease severity, and maternal-fetal status. Pregnancy complicated by hypertension should also be regarded as a marker of future cardiovascular risk, making structured post-partum surveillance clinically important.

Keywords: pre-eclampsia; gestational hypertension; chronic hypertension; pregnancy; aspirin; magnesium sulfate; maternal cardiovascular risk

Keywords
pre-eclampsia; gestational hypertension; chronic hypertension; pregnancy; aspirin; magnesium sulfate; maternal cardiovascular risk
Article Information
Volume

4

Year

2021

Review Rounds

1

Article Type

Research Article

Indexed In
Publish your academic thesis as a book with ISBN Contact – connectirj@gmail.com
Get In Touch

2/11, SASTRI NAGAR, KOYEMBEDU, CHENNAI-600107

9488577176

editor@irjweb.com, connectirj@gmail.com

Follow Us

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License

Copyrights © IRJEdT. All Rights Reserved.

Visiters Count :